# Village Farms Pilots THC Potency Range Labeling in British Columbia > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/thc-potency-range-labeling-bc-village-farms-pilot/ > **Published:** 2026-04-10T08:21:03-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:26:06-04:00 > **Clinical Summary:** Village Farms pilots THC potency range labeling to improve dosing accuracy and patient safety in British Columbia cannabis products. --- ✦ New CED Clinical Relevance  #78Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic DosingProduct QualityPatient SafetyThcLabeling Why This Matters Current single-point THC labeling creates unrealistic patient expectations and dosing confusion when actual potency varies significantly from the label. Range-based labeling could improve dosing accuracy and reduce adverse events from unexpected potency variations. Clinical Summary Village Farms is piloting THC potency range labeling (e.g., 18-22% THC) instead of single-point estimates on their cannabis products in British Columbia. This addresses the reality that cannabis potency naturally varies within batches due to biological factors, while current regulations require specific percentage claims that may not reflect actual product variability. The pilot aims to provide more accurate consumer information about the THC content patients will actually receive. Dr. Caplan’s Take “This is long overdue from a clinical safety perspective. I regularly see patients who experience unexpected effects because the actual THC content differs from what’s on the label — range labeling gives us the dosing reality we need to practice medicine safely.” Clinical Perspective 🧠 Clinicians should support this approach as it provides more honest dosing information for patient counseling. When recommending specific products, ask about actual potency testing and advise patients to start with lower doses when trying products with wider THC ranges. This change may reduce dosing-related adverse events and improve treatment predictability. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Village%20Farms%20pilots%20THC%20potency%20range%20labelling%20in%20BC%20-%20StratCann%20%40drcaplan&url=https%3A//stratcann.com/news/pure-sunfarms-pink-kush-label-thc/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//stratcann.com/news/pure-sunfarms-pink-kush-label-thc/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Village%20Farms%20pilots%20THC%20potency%20range%20labelling%20in%20BC%20-%20StratCann%20--%20via%20%40drcaplan.bsky.social%20https%3A//stratcann.com/news/pure-sunfarms-pink-kush-label-thc/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://stratcann.com/news/pure-sunfarms-pink-kush-label-thc/](https://stratcann.com/news/pure-sunfarms-pink-kush-label-thc/) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating for this cannabis news?](#What_is_the_clinical_relevance_rating_for_this_cannabis_news) - [What key areas does this cannabis research cover?](#What_key_areas_does_this_cannabis_research_cover) - [Why is this cannabis news considered clinically relevant?](#Why_is_this_cannabis_news_considered_clinically_relevant) - [What should healthcare providers know about cannabis dosing?](#What_should_healthcare_providers_know_about_cannabis_dosing) - [How does product quality affect cannabis treatment outcomes?](#How_does_product_quality_affect_cannabis_treatment_outcomes) - [Related](#Related) ## FAQ #### What is the clinical relevance rating for this cannabis news? This article has been assigned CED Clinical Relevance #78, indicating “Notable Clinical Interest.” This means the findings or policy developments are emerging and worth monitoring closely by [healthcare professionals](https://cedclinic.com/cannabis-reproductive-health-women-clinical-evidence/). #### What key areas does this cannabis research cover? The research focuses on several critical areas including dosing protocols, product quality standards, and patient safety measures. THC content and formulation are also key components being examined in this study. #### Why is this cannabis news considered clinically relevant? The article addresses emerging findings or policy developments in [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) that warrant close monitoring by clinicians. These developments may impact current treatment protocols and [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) standards. #### What should healthcare providers know about cannabis dosing? Proper dosing remains a critical consideration in [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/), as highlighted in this research. Healthcare providers should stay informed about emerging dosing guidelines and protocols to ensure safe and effective patient treatment. #### How does product quality affect cannabis treatment outcomes? Product quality is essential for consistent therapeutic effects and [patient safety in cannabis medicine](https://cedclinic.com/physician-guidance-cannabis-industry/). Standardized quality measures help ensure patients receive reliable, predictable treatment outcomes across different cannabis products. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Village Farms Pilots Potency Range Labeling in Canada | Cannabis Business Times](https://cedclinic.com/potency-range-labeling-cannabis-village-farms-pilot/) Explore the details of Village Farms' initiative to implement potency range labeling across Canadian cannabis products to enhance consumer information. [Read More](https://cedclinic.com/potency-range-labeling-cannabis-village-farms-pilot/) [Massachusetts Regulators Initiate Audits of Cannabis THC Potency Levels – Hemp Gazette](https://cedclinic.com/cannabis-thc-potency-regulation-ct-bill-update/) Learn about regulatory efforts in Massachusetts to audit and ensure accuracy in cannabis THC potency labeling for patient safety. [Learn More](https://cedclinic.com/cannabis-thc-potency-regulation-ct-bill-update/) [Review Finds Just 31% of Consumer CBD Products Meet Label-Accuracy Standard](https://cedclinic.com/review-finds-just-31-of-consumer-cbd-products-meet-label-accuracy-standard/) A critical review highlighting the challenges of label accuracy in [CBD products](https://cedclinic.com/fda-warning-on-cbd-products/) and implications for consumer trust and safety. [Discover Insights](https://cedclinic.com/review-finds-just-31-of-consumer-cbd-products-meet-label-accuracy-standard/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).